Tauklarify’s approval comes as the Alzheimer’s diagnostics field increasingly explores less invasive approaches, particularly blood-based tests for phosphorylated tau (pTau).
Polaroid Therapeutics designed POLTX_Fibers™ to help reduce infection risk while supporting wound healing at the point of care.
The Sepion 75 completes Syntegon’s established Sepion tablet coating range and is designed to support consistent scale-up, flexible batch processing and containment-focused manufacturing.
The new software incorporates AI-powered nodule segmentation, which is designed to generate more precise boundaries around lung nodules during pre-procedural planning.
Rather than creating entirely new programmes, HPPI has worked to strengthen TB services within established HIV platforms while using a person-centred, community-led approach.
The company recorded non-IFRS net profit of RMB 97.23 million (US$13.7 million), while its IFRS net loss narrowed 98% year-on-year. Everest ended the period with RMB 1.859 billion (US$261.8 million) in cash.
Under the agreement, LEO will pay up to US$435 million in upfront and near-term milestone payments for global rights to dersimelagon.
Tirzepatide has gained attention as a treatment option for metabolic conditions, particularly because of its role in managing blood glucose levels and supporting weight management in eligible patients.
The company said the kit simplifies the RT-qPCR workflow by eliminating RNA extraction, reducing sample preparation time and limiting the number of handling steps required before gene expression analysis.
Under the milestone-based agreement, Sandoz could pay Henlius up to US$322 million, including near-term payments of up to US$100.5 million linked to the initial assets.